Skip to main content
. Author manuscript; available in PMC: 2018 Mar 28.
Published in final edited form as: J Labelled Comp Radiopharm. 2017 Jul 25;61(3):252–262. doi: 10.1002/jlcr.3528

Table 2.

Radiotracers synthesized using vial and “in-loop” [11C]CO2-fixation

Entry Compound Vial methoda “In-loop” methodb RCP (%)e Synthesis time (min) Radioactivity at EOS (GBq (mCi))f Molar radioactivity (GBq/μmol)g

RCY(%)c, d RCY(%)c, d
1 [11C]2 33 70 (43)h >99 35 10.2±2.8 (276±74) 134±21
2 [11C]5 5 72 (54)h >99 33 14.3 (387) 84
3 [11C]7 2 30 (18)h >99 38 3.8 (102) 80
a

Conditions for vial reaction. (1) Precursor 1 (0.6 μmol); primary amines 3 and 6 (110 and 150 μmol, respectively); BEMP (5 μL, 34.6 μmol), DMF (80 μL); (2) 0.2% POCl3 (v/v) in MeCN (100 μL, 1.1 μmol); (3) secondary amine (4) in DMF (100 μL).

b

Conditions for “in-loop” reaction. (1) Precursor 1 (0.3 μmol); primary amines 3 and 6 (55 and 75 μmol, respectively); BEMP (2.5 μL, 17.3 μmol), DMF (40 μL); (2) 0.2% POCl3 (v/v) in MeCN (100 μL, 1.1 μmol); (3) secondary amine (4) in DMF (50 μL).

c

Non-isolated radiochemical yield (RCY), based on radio-HPLC analysis of the crude product.

d

Experiments were performed once (n=1).

e

Radiochemical purity (RCP) of the isolated product.

f

Total amount of the isolated product at the end-of-synthesis.

g

Molar radioactivity of the isolated product established by HPLC.

h

The decay-corrected radiochemical yield of the isolated product obtained after semi-preparative HPLC and formulation.